AN2 Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2022 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
AN2 Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q4 2023.
  • AN2 Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2023 was 875 %, a 58.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 875 -1.25K -58.8% Dec 31, 2023
Q3 2023 991 -1.38K -58.2% Sep 30, 2023
Q2 2023 1.26K Jun 30, 2023
Q1 2023 1.7K Mar 31, 2023
Q4 2022 2.12K Dec 31, 2022
Q3 2022 2.37K Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.